Zobrazeno 1 - 10
of 89
pro vyhledávání: ''
Autor:
Friedegund Meier, Lydia Reinhardt, M. Schlaak, Katharina C. Kähler, Bastian Schilling, Lisa Zimmer, Valerie Glutsch, Sebastian Haferkamp, Alvaro Moreira, Tabea Wilhelm, Frank Meiss, Manuel Philip, Ralf Gutzmer, Alexander Roesch, Susanne Horn, Antje Sucker, Anne Zaremba, Selma Ugurel, Lucie Heinzerling, David Rafei-Shamsabadi, Jochen Utikal, Elisabeth Livingstone, Dirk Schadendorf, Carsten Weishaupt, Nadine Stadtler, Zeno Fiocco, Carmen Loquai, Felix Kiecker, Jessica C. Hassel, Claudia Pföhler, Kai-Martin Thoms
Publikováno v:
European journal of cancer (Oxford, England : 1990). 152
Introduction Cutaneous melanoma is notorious for the development of in-transit metastases (ITM). For unknown biological reasons, ITM remain the leading tumour manifestation without progression to distant sites in some patients. Methods In total, 191
Autor:
Julius Moratin, Subramania Iyer, Christian Freudlsperger, Linda Feeley, Ruta Gupta, Davide Mattavelli, Krishnakumar Thankappan, Carsten E. Palme, Kan Gao, Alfons J. M. Balm, Tsu-Hui Hubert Low, Cesare Piazza, Therese Ovesen, Chris Milross, Mischa de Ridder, Jonathan R. Clark, Yogesh Dokhe, Patrick Sheahan, Narayana Subramaniam, Sana D. Karam, Susanne Wiegand, Deepak Balasubramanian, Maria Pedersen, Christian Mirian, Thomas A. Gerds, Lasse Rehné Jensen
Publikováno v:
European journal of cancer (Oxford, England : 1990). 150
Background We aimed to compare the predictive performance of pN-categories in oral squamous cell carcinoma (OSCC) encompassing the most recent 8th edition (TNM8), its predecessor (TNM7), and a newly proposed algorithm (pN-N+), which classifies patien
Autor:
Dario Neri, Torsten Kessler, Walter Heindel, Wolfgang E. Berdel, Wolfgang Hartmann, Jan Philipp Hering, Eva Wardelmann, Georg Lenz, Linus Angenendt, Filippo de Braud, Teresa Hemmerle, Andrea Kerkhoff, Sant P. Chawla, Christoph Schliemann, Andrew F. Berdel
Publikováno v:
European journal of cancer (Oxford, England : 1990). 150
Background L19TNF is a recombinant fusion protein composed of a human antibody fragment and human tumour necrosis factor. L19TNF targets the EDB domain of oncofetal fibronectin highly expressed in tumour vasculature and induces tumour remission in mo
Autor:
Karen A. Gelmon, Peter A. Fasching, Fergus J. Couch, Judith Balmaña, Suzette Delaloge, Intidhar Labidi-Galy, James Bennett, Susan McCutcheon, Graham Walker, Joyce O'Shaughnessy, Constanta Timcheva, Antoaneta Tomova, Andrea Eisen, Karen Gelmon, Julie Lemieux, Fernando Bazan, Hugues Bourgeois, Camille Chakiba, Mohamad Chehimi, Florence Dalenc, Thibault De La Motte Rouge, Jean-Sébastien Frenel, Anthony Gonçalves, Anne Claire Hardy-Bessard, Regine Lamy, Christelle Levy, Alain Lortholary, Audrey Mailliez, Jacques Medioni, Anne Patsouris, Dominique Spaeth, Luis Teixeira, Isabelle Tennevet, Cristian Villanueva, Benoit You, Johannes Ettl, Bernd Gerber, Oliver Hoffmann, Tjoung-Won Park-Simon, Mattea Reinisch, Joke Tio, Pauline Wimberger, Katalin Boer, Alberto Ballestrero, Giampaolo Bianchini, Laura Biganzoli, Roberto Bordonaro, Francesco Cognetti, Michelino De Laurentiis, Sabino De Placido, Valentina Guarneri, Filippo Montemurro, Giuseppe Naso, Armando Santoro, Claudio Zamagni, Seung-Jin Kim, Seigo Nakamura, Yee Soo Chae, Eun Kyung Cho, Kim Jee Hyun, Seock-Ah Im, Keun Seok Lee, Yeon Hee Park, Joo Hyuk Sohn, Tomasz Byrski, Tomasz Huzarski, Bozena Kukielka-Budny, Zbigniew Nowecki, Renata Szoszkiewicz, Rafal Tarnawski, Viktoria Dvornichenko, Fedor Moiseenko, Guzel Mukhametshina, Elena Poddubskaya, Ekaterina Popova, Anna Tarasova, Anna Vats, Bárbara Adamo, Raquel Andrés Conejero, Antonio Antón Torres, Judith Balmaña Gelpi, Nieves Díaz Fernández, Alejandro Falcón González, Juan Garcia, Isabel Lorenzo-Lorenzo, Fernando Moreno Antón, Marta Santisteban, Agostina Stradella, Chiun-Sheng Huang, Sercan Aksoy, Cagatay Arslan, Mehmet Artac, Adnan Aydiner, Ozgur Ozyilkan, Emel Sezer, Anne Armstrong, Sophie Barrett, Annabel Borley, Zoe Kemp, Caroline Michie, Mukesh Mukesh, Timothy Perren, Angela Swampillai, Tammy Young
Publikováno v:
European journal of cancer (Oxford, England : 1990). 152
Background In the phase III OlympiAD trial, olaparib significantly increased progression-free survival (PFS) compared with chemotherapy of physician's choice in patients with germline BRCA-mutated (gBRCAm), human epidermal growth factor 2 (HER2)-nega
Autor:
E. Novel-Catin, Stéphane Dalle, Denis Fouque, C. Teuma, M. Espi, Pierre-Jean Souquet, Denis Maillet, Laetitia Koppe
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2021, 147, pp.29-39. ⟨10.1016/j.ejca.2021.01.005⟩
European Journal of Cancer, Elsevier, 2021, 147, pp.29-39. ⟨10.1016/j.ejca.2021.01.005⟩
European Journal of Cancer, 2021, 147, pp.29-39. ⟨10.1016/j.ejca.2021.01.005⟩
European Journal of Cancer, Elsevier, 2021, 147, pp.29-39. ⟨10.1016/j.ejca.2021.01.005⟩
Acute Kidney Injury (AKI), induced by Checkpoint Inhibitors therapies (CPI-induced AKI), is an uncommon but severe Immune-Related Adverse Event (IRAE). The aim was to describe the epidemiology, risks factors, clinical, and laboratory characteristics
Publikováno v:
European journal of cancer (Oxford, England : 1990). 145
Aim Salpingectomy is associated with a lower risk for ovarian cancer, suggesting that the fallopian tubes constitute the origin of the disease. It is unclear whether the observed effect is mediated by pelvic inflammatory disease (PID); a major indica
Autor:
Georgios Stamatis, Nika Guberina, Clemens Aigner, Thomas Gauler, Martin Stuschke, Maja Guberina, Dirk Theegarten, Wilfried Eberhardt, Kaid Darwiche, Martin Metzenmacher, Martin Schuler, Christoph Pöttgen, Till Plönes, Karl-Heinz Jöckel, Bettina Krebs
Publikováno v:
European journal of cancer (Oxford, England : 1990). 138
Background The optimal treatment for patients with locally advanced non-small-cell lung-cancer (NSCLC) cT4 cN0/1 cM0 is still under debate. The purpose of this study was to examine the long-term survival of cT4 cN0/1 cM0 NSCLC patients undergoing ind
Autor:
Véronique Duchatelle, Diane Damotte, Y. Velut, R. Herbst, Ludovic Fournel, G. Boulle, Scott A. Hammond, M. Wislez, Isabelle Cremer, Laure Gibault, Philippe Giraud, Hélène Blons, Marco Alifano, Audrey Mansuet-Lupo, A. Boni, Jean Trédaniel
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 135, pp.221-229. ⟨10.1016/j.ejca.2020.04.040⟩
European Journal of Cancer, 2020, 135, pp.221-229. ⟨10.1016/j.ejca.2020.04.040⟩
European Journal of Cancer, Elsevier, 2020, 135, pp.221-229. ⟨10.1016/j.ejca.2020.04.040⟩
European Journal of Cancer, 2020, 135, pp.221-229. ⟨10.1016/j.ejca.2020.04.040⟩
Background Radiotherapy is a standard of care for locally advanced stage III N2 non–small-cell lung carcinoma (NSCLC) combined with surgery/chemotherapy. Radiotherapy is hypothesised to induce tumour immunogenic cell death, to release neoantigen re
Autor:
Sylvie Negrier, Alain Ravaud, Philippe Barthélémy, Olivier Huillard, Valérie Seegers, Carolina Saldana, Delphine Borchiellini, Manon de Vries-Brilland, Bernard Escudier, Sylvain Ladoire, Elouen Boughalem, Constance Thibault, Gwenaelle Gravis, Antoine Thiery-Vuillemin, Lionnel Geoffrois, Laurence Albiges, Christine Chevreau, Marine Gross-Goupil, Benoit Beuselinck
Publikováno v:
European journal of cancer (Oxford, England : 1990). 136
Background Papillary renal cell carcinoma (pRCC) is the most common non-clear cell RCC (nccRCC). Pivotal studies evaluating immune checkpoint inhibitors mostly excluded nccRCC. The aim of this retrospective and multicentre study was to evaluate the a
Autor:
Christophe Hennequin, Thomas Aparicio, Jean-Marc Gornet, Jacques Lerman, Laurent Quero, Sophie Guillerm, Alain Valverde, Gaël Goujon, Laurent Abramowitz, Pierre Cattan, Isabelle Etienney
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 141, pp.143-151. ⟨10.1016/j.ejca.2020.09.039⟩
European Journal of Cancer, Elsevier, 2020, 141, pp.143-151. ⟨10.1016/j.ejca.2020.09.039⟩
International audience; Purpose: Anal squamous cell carcinoma is associated with multiple risk factors, including infection with human papillomavirus and human immunodeficiency virus, immunosuppression, multiple sex partners, receptive anal sex and t